A recent study evaluated the effect of Orlistat (a drug normally used to treat obesity) on the gene expression of OCT4, NANOG, SOX2, and KLF4 in the CRC cancer cell line SW40. The gene discussed is NANOG; the disease is colorectal carcinoma.